Modification of the recognition of restriction sites of plasmid DNA by the antitumor drug Pt-pentamidine

Biochemical Pharmacology

Volumn 52, Issue 6, 1996, Pages 851-856

  Pérez, José M ^a   Gonzalez, Victor M ^a   Fuertes, Miguel A ^a   Alonso, Carlos ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

cis Pt(II); DNA interactions; Pt pentamidine

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; PENTAMIDINE ISETHIONATE; PLASMID DNA; PLATINUM COMPLEX; PLATINUM PENTAMIDINE; RESTRICTION ENDONUCLEASE; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BINDING SITE; COMPLEX FORMATION; CONTROLLED STUDY; COVALENT BOND; DNA BINDING; DNA MODIFICATION; ESCHERICHIA COLI; GEL ELECTROPHORESIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0030603968     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00351-6     Document Type: Article

References (17)

1. 1. Umapathy P, The chemical and biochemical consequences of the binding of the antitumour drug cisplatin and other platinum group metal complexes to DNA. Coord Chem Rev 95: 129-181, 1989.
2. 2. Newman PC, Williams DM, Cosstick R, Seela F and Conolly BA, Interaction of the EcoRV restriction endonuclease with the deoxyadenosine and thymidine bases in its recognition hexamer d(GATATC). Biochemistry 29: 9902-9910, 1990.
3. 3. Lippert B, From cisplatin to artificial nucleases - the role of metal ion-nucleic acid interactions in biology. Biometals 5: 195-208, 1992.
4. 4. Pinto AL, Lippard SJ, Binding of the antitumor drug cis-diamminedichloroplatinum (II) (cisplatin) to DNA. Biochem Biophys Acta 780: 167-180, 1985.
5. 5. Ushay HM, Tullius TD and Lippard SJ, Inhibition of the Bam HI cleavage and unwinding of pBR3222 deoxyribonucleic acid by the antitumour drug cis-dichlorodiammineplatinum (II). Biochemistry 21: 3744-3748, 1981.
6. 6. Cohen GL, Bauer WR, Barton JK and Lippard SJ, Binding of cis- and trans-dichlorodiammine platinum (II) to DNA: Evidence for unwinding and shortening of the double helix. Science 203: 1014-1015, 1979.
7. 2 tetrachloroplatinum (II) and potassium tetrachloroplatinate "in vitro" and "in vivo." Cancer Res 48: 2335-2341, 1988.
8. 8. Brabec V and Balcarova Z, Restriction-enzyme cleavage of DNA modified by platinum(II) complexes. Eur J Biochem 216: 183-187, 1993.
9. 9. Kelman AD and Buchbinder M, Platinum-DNA crosslinking: platinum antitumor drug interactions with native lambda bacteriophage DNA studies using a restriction endonuclease. Biochimie 60: 893-899, 1978.
10. 10. Cohen GL, Ledner JA, Bauer WR, Ushay HM, Caravana C and Lippard SJ, Sequence dependent binding of cis-diammine dichloroplatinum (II) to DNA. J Am Chem Soc 102: 2487-2488, 1980.
11. 11. Pérez JM, Navarro-Ranninger MC, Requena JM, Jiménez-Ruíz A, Craciunescu D, Parrondo E, López MC and Alonso C, DNA binding properties and antileukemic activity of a Pt-pentamidine complex. Chem-Biol Interact 77: 341-355, 1991.
12. 12. Pérez JM, Requena JM, Craciunescu D, López MC and Alonso C, The anti Z-DNA reactivity of Z-DNA forming sequences is affected by platinum antitumor drugs. J Biol Chem 268: 24774-24778, 1993.
13. 13. Pérez JM, Requena JM, Craciunescu D, Doadrio JC and Alonso C, Binding of Pt-pentamidine to nucleosomal DNA. Studies of the antiproliferative activity of the drug against human cancer cells. Chem-Biol Interact 89: 61-72, 1993.
14. 14. Maniatis T, Fritsch EF and Sambrook J, Molecular Cloning, a laboratory manual. Cold Spring Harbor Laboratory Press, New York, 1989.
15. 15. Viera J and Messing J, The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene 19: 259-268, 1982.
16. 16. Eastman A, Reevaluation of interaction of cis-dichloro (ethylenediamine) platinum (II) with DNA. Biochemistry 25: 3912-3915, 1986.
17. 17. López MC, Ruíz LM, Craciunescu D, Doadrio A, Osuna A and Alonso C, Studies on the interaction between antitry-panosome cis-DDP analogs with DNA. Chem-Biol Interact 59: 99-111, 1986.